A Predictive Score for the Ischemic Etiology of a Transient Diplopia (VASCO-DIP)
VASCO-DIP
Development and Validation of a Predictive Score for the Ischemic Etiology of a Transient Diplopia
1 other identifier
observational
220
1 country
2
Brief Summary
The transient diplopias (TD) is defined by a short diplopia. Their etiology may be ophthalmological, neurological non-ischemic or of ischemic origin. The difficulty is to recognize an ischemic mechanism which imposes emergency cares. A clinical score could help the clinician to recognize the etiology of the TD .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2015
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 24, 2015
CompletedFirst Submitted
Initial submission to the registry
October 13, 2015
CompletedFirst Posted
Study publicly available on registry
October 15, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 23, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 23, 2025
CompletedJune 25, 2025
June 1, 2025
10 years
October 13, 2015
June 19, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Etiology, ischemic or not, of the initial transient diplopia
Questionnaire about the symptoms and about the vascular risk factors, cerebral MRI, MRI angiography of the supra-aortic trunks, ECG, Holter, transthoracic echocardiography, blood count, erythrocytes sedimentation rate, C reactive protein, visual field, optical coherence tomography, retinography and a new evaluation after 3 months.
3 months
Secondary Outcomes (4)
Incidence of new transient diplopia ischemic attacks during the 3 months of follow-up
3 months
Incidence of diplopia ischemic strokes during the 3 months of follow-up
3 months
Incidence of transient ischemic attacks, visual or not visual, during the 3 months of follow-up
3 months
Incidence of ischemic strokes, visual or not visual, during the 3 months of follow-up
3 months
Study Arms (1)
Eligible patients
Adults having had a transient diplopia during the last 8 days.
Interventions
Clinical : questionnaire about the symptoms and about the vascular risk factors Imagery :Cerebral MRI, MRI angiography of the supra-aortic trunks, ECG, Holter, transthoracic echocardiography, Biology : blood count, erythrocytes sedimentation rate, C reactive protein Ophthalomogy : visual field, optical coherence tomography, retinography
Eligibility Criteria
Adults having had a transient diplopia during the last 8 days and seen at the fondation ophtalmologique Adolphe de Rothschild
You may qualify if:
- Transient diplopia (i.e. less than 24 hours) during the last 8 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hôpital Bichat
Paris, 75018, France
Fondation Ophtalmologique Adolphe de Rothschild
Paris, Île-de-France Region, 75019, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 13, 2015
First Posted
October 15, 2015
Study Start
September 24, 2015
Primary Completion
September 23, 2025
Study Completion
December 23, 2025
Last Updated
June 25, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share